Acro Biomedical Co., Ltd.

ACBM · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$42-$8,808-$15,871-$7,698
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$8,061$15,712$7,651
Change in WC$1$158$10$341
Other Non-Cash$4$573$2$4
Operating Cash Flow-$37-$15-$147$299
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$37$10$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$58-$222
Financing Cash Flow$37$10$58-$222
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$5-$89$77
Supplemental Information
Beg. Cash$0$6$95$18
End Cash$0$0$6$95
Free Cash Flow-$37-$15-$147$299